The National Quality Forum (NQF) is seeking public comments until Feb. 27 on 16 cardiovascular measures. Two of the 16 measures were submitted by the ACC Foundation/American Heart Association Task Force on Performance Measures and the American Medical Association Physician Consortium for Performance Improvement (ACC/AHA/AMA PCPI) and are related to atrial fibrillation.

The public comment period provides an opportunity for members of the cardiovascular community and other stakeholders to play an active role in the development of performance measures that could have a direct impact on hospitals and facilities. ACC/AHA/AMA PCPI have committed significant resources over the years to both developing and testing cardiovascular measures. The measures submitted meet key attributes of measurement and include:

1. NQF 1524: Atrial Fibrillation: Assessment of Thromboembolic Risk Factors (CHADS2) (ACC/AHA/AMA PCPI). This measure is not proposed for re-endorsement.
2. NQF 1525: Atrial Fibrillation and Atrial Flutter: Chronic Anticoagulation Therapy (ACC/AHA/AMA PCPI). This measure is proposed for re-endorsement.

Following the comment period, the NQF Cardiovascular Committee will review the comments and make their final recommendations to the NQF Board. Official endorsement from NQF would better ensure ACC/ AHA/AMA PCPI developed measures would be included in key national public reporting and payment programs. While this process is lengthy, your support and comments are critical to ensuring ACC’s continued success at NQF. To this end, we encourage you to submit comments via the NQF website by Feb. 27. In order to comment on the measures, you must have an NQF log on. If you do not have one, you can set one up here.

Keywords: Advisory Committees, American Heart Association, American Medical Association, Atrial Fibrillation, Atrial Flutter, Cardiovascular Diseases, Cardiovascular System, Residence Characteristics, Risk Factors, United States

< Back to Listings